The present review will depict the importance of glucose transport in healthy and diseased heart, as well as proposed therapies targeting glucose transporters
Media Releases - 19 January 2026 Health Minister Mark Butler has committed to listing Wegovy on the PBS for people who have had a heart attack or stroke, or people with a Body Mass Index (BMI) of 35 or higher, as recommended by the Pharmaceutical Benefits Advisory Committee (PBAC) late last year
This conversation is a powerful reminder that prevention, early intervention, and personal accountability are the foundations of long-term vitality
Introduction If youre taking a GLP1 medication like semaglutide or tirzepatide (sold as Mounjaro, Zepbound, Ozempic, and Wegovy), youve likely heard that rotating injection sites is a good idea but why does it matter, and how do you actually keep track of it
Published: Aug 27, 2024 Written by Amelia Willson Medically Reviewed by Dhruv Patel, BSPS, RPh Published: Aug 27, 2024 Key takeaway: Semaglutide typically begins suppressing appetite within 1-2 weeks of the first dose, with full appetite control building over 4-8 weeks as the dose escalates